Last edition
News about " antibacterial drug regimen"
FDA Grants Priority Review to Insmed's Arikayce sNDA
Insmed’s Arikayce sNDA receives FDA Priority Review for the treatment of MAC lung disease, with a PDUFA target action date of January 28, 2027.
Antibacterial Drug Regimen | 22/09/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members